Markus Schmitt

Founder and CEO @Multiplexion Gmbh

Friedrichshafen, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jun 2012 — Present

Founder and CEO @Multiplexion Gmbh

View department →

Cell culture contaminations are a serious problem in biological research. Possible reasons are mostly mishandling of cells during routine culture and cryopreservation but also the lack of convenient tests for the quality control of cell cultures. The result is that 15-30 % of cell lines in current use are estimated to be contaminated or to not be what they are thought to be.In principle, cell lines can be contaminated by a wide range of agents including i) bacteria, ii) viruses and other cell lines. Frequent bacterial, viral and inter-species contaminations can be rapidly detected by Multiplexion´s Multiplex cell Contamination Test (McCT), whereas a contamination of one human cell line by another human cell line (intra-human contamination) and the authentication of human cell lines is monitored by Multiplexion´s Multiplex Cell Authentication (MCA).

EDUCATION

2005 — 2008

Heidelberg University

PhD, Virology

2002 — 2003

University College Dublin

Molecular biology

2000 — 2005

Heidelberg University

Dipl. Biol., Molecular biology, biochemistry

2005 — 2008

DKFZ German Cancer Research Center

Doctor of Philosophy - PhD, Oncology and Cancer Biology

SKILLS

GeneticsCervical CancerAssay DevelopmentQpcrBiomarker DevelopmentCancer ResearchDna SequencingVirologyMolecular BiologySas ProgrammingCell CultureEpidemiologyLife SciencesCell BiologyBiotechnologyPcrQ-PcrCellNgsLuminex

ABOUT MARKUS SCHMITT

As Head of R&D for Next Generation Sequencing (NGS) and oligonucleotide synthesis, I lead a multidisciplinary team of 10 scientists and technicians in driving innovation and development of cutting-edge genomic technologies. With a robust foundation in molecular biology and extensive hands-on experience in NGS platforms (Illumina, ONT, PacBio), molecular diagnostics, and assay development, I oversee the design and implementation of high-throughput, multiplexed nucleic acid assays that push the boundaries of precision and scalability.My expertise spans advanced molecular techniques including NGS, qPCR, droplet digital PCR, and Luminex-based multiplexing, applied to diagnostics and research applications such as cervical cancer screening and cell line authentication.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Markus Schmitt — Founder and CEO at Multiplexion Gmbh in Friedrichshafen, DE | Unifers